Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin to Extend Diabetes Remission After Bariatric Surgery
NCT04581447Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2021
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2021; status: recruiting.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04581447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04581447.